市場調査レポート
商品コード
1071677
インスリン注射器の世界市場規模:エンドユーザー別(病院・診療所、在宅医療現場、その他)、疾患別(1型糖尿病、2型糖尿病)、地域別の予測(2021年~2027年)Global Insulin Syringes Market Size study, by End-Use (Hospitals & Clinics, Homecare Settings and Others), by Diseases (Type 1 Diabetes and Type 2 Diabetes) and Regional Forecasts 2021-2027 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
インスリン注射器の世界市場規模:エンドユーザー別(病院・診療所、在宅医療現場、その他)、疾患別(1型糖尿病、2型糖尿病)、地域別の予測(2021年~2027年) |
出版日: 2022年04月22日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
世界のインスリン注射器の市場規模は、糖尿病の有病率の上昇、老年人口の急増、発展途上国の高い成長ポテンシャルなどによって促進されています。
一方で、インスリンの高価格が予測期間中の同市場の成長を抑制する可能性があります。
当レポートでは、世界のインスリン注射器市場を調査しており、市場の概要、市場分析、エンドユーザー・疾患・地域別の分析、および競合情勢など、包括的な情報を提供しています。
List of figures
Global Insulin Syringes Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Insulin regulates fat and carbohydrate metabolism in the body. It is a peptide hormone, which is secreted in the pancreas by beta cells of the islets of Langerhans and it helps to regulate glucose metabolism. An insulin syringe aids in delivering insulin to diabetic patients in required doses. The rise in prevalence of diabetes and surge in the geriatric population has led to the adoption of Insulin Syringes across the forecast period. For Instance: as per the WHO in 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes and in 2019, about 462 million individuals were affected by type-2 diabetes, corresponding to 6.28% of the world's population. Also, with the high growth potential in developing countries, the adoption & demand for Insulin Syringes is likely to increase the market growth during the forecast period. However, high price of insulin impedes the growth of the market over the forecast period of 2022-2028.
The key regions considered for the Global Insulin Syringes Market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading region across the world in terms of market share owing to the favorable government policies related to insulin syringes. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027. Factors such as rising population, rising incidences of injuries and improving healthcare infrastructure would create lucrative growth prospects for the Insulin Syringes market across Asia-Pacific region.
Major market players included in this report are:
Hindustan syringe and medical device Ltd.
Novo Nordisk A/S
Biocon Ltd
Abbott Laboratories
Terumo Corporation
Cardinal Health Inc
Beckton and Dickinson Company
Eli Lilly and Company
Nipro Medical Corporation
Medline Industries
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By End-Use:
Hospitals & Clinics
Homecare Settings
Others
By Diseases:
Type 1 Diabetes
Type 2 Diabetes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Insulin Syringes Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors